Property | Value |
?:abstract
|
-
Exogenous surfactant therapy has been widely studied in acute respiratory distress syndrome (ARDS) but has failed to show mortality benefit in several ... »more»
|
?:creator
|
|
?:doi
|
|
?:doi
|
-
10.1080/24745332.2020.1843202
|
?:externalLink
|
|
?:license
|
|
?:pdf_json_files
|
-
document_parses/pdf_json/79b0502f96be5ee5268b89f6f2a2f3e8e2949f4e.json
|
?:pmcid
|
|
?:publication_isRelatedTo_Disease
|
|
is
?:relation_isRelatedTo_publication
of
|
|
?:sha_id
|
|
?:source
|
|
?:title
|
-
Considerations for the use and study of exogenous surfactant in respiratory disease from COVID-19
|
?:type
|
|
?:year
|
|